Memphis Pharmaceuticals (MPCI.CA) - Company's Response to the Central Auditing Organization Report
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Company's response to the Central Auditing Organization Report for the estimated budget for the fiscal year 2021/2022.
News Attachment (383 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Company's response to the Central Auditing Organization Report for the estimated budget for the fiscal year 2021/2022.
News Attachment (383 KB)
Comments